University of Leicester
Browse
systreview phage clincial trial protocol_.pdf (270.05 kB)

Overview of systematic reviews of the effectiveness/ efficacy and toxicity of phage therapy in treating bacterial infections in humans. Protocol for the literature review

Download (270.05 kB)
report
posted on 2023-08-18, 14:53 authored by M N Vieu, P Robson, M Haynes

Background to the review

Antimicrobial resistance of bacteria causing common infections, such as Urinary Tract Infections (UTIs), is increasing and generating additional health and societal burdens.

While resistance is a natural phenomenon, it has been exacerbated and accelerated by antibiotic use in both human and animals.

While reducing antibiotic use can contribute to reduce the risk of resistance, antibiotics are required to allow modern medical interventions.

Bacteriophages are widely available and have been used for over 100 years. There is a potential in using phage therapy for both common infections and severe infections resistant to mainstream antibiotics, thus “protecting the medicines that protect us” (as stated by WHO “Thirteen urgent health challenges for next decade” 13th January 2020). However, phage therapy has not been tested under modern clinical procedures and regulations in Europe and developing clinical trials of phage therapy is required. The University of Leicester is working on developing clinical trials of phage therapy for UTIs and this overview will contribute to it.

History

Author affiliation

Department of Genetics and Genome Biology, University of Leicester

Version

  • VoR (Version of Record)

Publisher

University of Leicester

Copyright date

2023

Available date

2023-08-18

Language

en

Usage metrics

    University of Leicester Reports and One-off Publications

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC